Prudence Kgagudi

National Health Laboratory Service — South Africa

Medicine · Health Sciences

18h-index2.9kcitations45works2.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

SARS-CoV-2 and COVID-19 Research(28), COVID-19 Clinical Research Studies(14), HIV Research and Treatment(12), vaccines and immunoinformatics approaches(8), HIV/AIDS drug development and treatment(6)

Publications45 total

Rapid elicitation of neutralizing Asn332-glycan-independent antibodies to the V3-glycan epitope of HIV-1 Env in nonhuman primates
Nature Immunology·2026· 1 citedOpen Access
Identification of a potent V3 glycan site broadly neutralizing antibody targeting an N332gp120 glycan-independent epitope
Nature Immunology·2026· 2 citedOpen Access
Vaccine elicitation of HIV-1 neutralizing antibodies against both V2 apex and fusion peptide in rhesus macaques
Cell Reports·2026Open Access
Humoral and cellular immunogenicity of COVID-19 vaccine boosters in participants with advanced HIV disease
Journal of Infection·2026Open Access
Neutralizing and binding antibodies are a correlate of risk of COVID-19 in the CoVPN 3008 study in people with HIV
UNC Libraries·2025Open Access
Neutralizing and binding antibodies are a correlate of risk of COVID-19 in the CoVPN 3008 study in people with HIV
Nature Communications·2025· 1 citedOpen Access
Rapid loss of activity but not serum concentration in a passive infusion clinical trial of an HIV neutralizing antibody
2025· 1 citedOpen Access
A Global Collaborative Comparison of SARS-CoV-2 Antigenicity Across 15 Laboratories
Viruses·2024· 3 citedOpen Access
Safety and immunogenicity of booster vaccination and fractional dosing with Ad26.COV2.S or BNT162b2 in Ad26.COV2.S-vaccinated participants
PLOS Global Public Health·2024· 10 citedOpen Access
Development of LIBRA-seq for the guinea pig model system as a tool for the evaluation of antibody responses to multivalent HIV-1 vaccines
Journal of Virology·2023· 3 citedOpen Access
Safety and immunogenicity of booster vaccination and fractional dosing with Ad26.COV2.S or BNT162b2 in Ad26.COV2.S-vaccinated participants
2023· 4 citedOpen Access
Development of LIBRA-seq for the Guinea Pig Model System as a Tool for the Evaluation of Antibody Responses to Multivalent HIV-1 Vaccines
2023Open Access
Neutralization profiles of HIV-1 viruses from the VRC01 Antibody Mediated Prevention (AMP) trials
UNC Libraries·2023Open Access
Despite delayed kinetics, people living with HIV achieve equivalent antibody function after SARS-CoV-2 infection or vaccination
Frontiers in Immunology·2023· 13 citedOpen Access
Neutralization profiles of HIV-1 viruses from the VRC01 Antibody Mediated Prevention (AMP) trials
PLoS Pathogens·2023· 44 citedOpen Access
Novavax NVX-COV2373 triggers neutralization of Omicron sub-lineages
Scientific Reports·2023· 46 citedOpen Access
Antibody-dependent cellular cytotoxicity against SARS-CoV-2 Omicron sub-lineages is reduced in convalescent sera regardless of infecting variant
Cell Reports Medicine·2022· 18 citedOpen Access
Novavax NVX-COV2373 triggers potent neutralization of Omicron sub-lineages
Research Square (Research Square)·2022· 2 citedOpen Access
Enhanced neutralization potency of an identical HIV neutralizing antibody expressed as different isotypes is achieved through genetically distinct mechanisms
Scientific Reports·2022· 13 citedOpen Access
Dependence on a variable residue limits the breadth of an HIV MPER neutralizing antibody, despite convergent evolution with broadly neutralizing antibodies
PLoS Pathogens·2022· 1 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Penny L. Moore(34), Bronwen E. Lambson(22), Thandeka Moyo-Gwete(19), Simone I. Richardson(19), Tandile Hermanus(18), Lynn Morris(14), Haajira Kaldine(14), Nelia P. Manamela(14), Frances Ayres(12), Jinal N. Bhiman(12), Theresa M. Rossouw(10), Veronica Ueckermann(10), Shabir A. Madhi(10), Nonhlanhla N. Mkhize(10), Zanele Makhado(10), Carolyn Williamson(10), Wendy A. Burgers(10), Linda‐Gail Bekker(10), Michael T. Boswell(9), Nigel Garrett(9)